- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Gillian M. Russell
Events 23 results
Speaking Engagement
October 16, 2024
Gillian Russell to Speak at FDLI’s Introduction to Advertising and Promotion for Medical Products Conference
Speaking Engagement
October 8, 2024
Nikki Reeves and Gillian Russell to Speak at the Seton Hall Compliance Congress
Webinar
September 18, 2024
Addressing Misinformation: Insights on Social Media and Influencer Marketing
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Webinar
January 17, 2024
Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2023 FDA Enforcement Letters and Other Key Developments
Webinar
December 11, 2023
#Sponsored: Influencer Marketing 201 for Pharmaceutical and Medical Device Companies
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
October 10, 2023
Nikkie Reeves and Gillian Russell to Speak at Seton Hall Law’s US Healthcare Compliance Certificate Program (USHCCP)
Speaking Engagement
February 23, 2023
Gillian Russell to Speak at DIA’s Advertising and Promotion Regulatory Affairs Conference
Speaking Engagement
February 23, 2023
Nikki Reeves, Heather Banuelos, Gillian Russell to Speak at DIA Global’s Advertising and Promotion Regulatory Affairs Conference
Webinar
January 24, 2023
Year in Review for Drug and Device Advertising and Promotion: Lessons Learned From 2022 FDA Enforcement Letters and Other Key Developments
Conference
November 1, 2022
Pharmaceutical University 2022